Tourmaline Bio, Inc. Quarterly Marketable Securities, Current in USD from Q4 2020 to Q3 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of investment in marketable security, classified as current.
Summary
Tourmaline Bio, Inc. quarterly Marketable Securities, Current history and growth rate from Q4 2020 to Q3 2023.
  • Tourmaline Bio, Inc. Marketable Securities, Current for the quarter ending September 30, 2023 was $79.9M, a 54.4% decline year-over-year.
Marketable Securities, Current, Quarterly (USD)
Marketable Securities, Current, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2023 $79.9M -$95.5M -54.4% Sep 30, 2023 10-Q 2023-11-14
Q2 2023 $134M -$47.7M -26.3% Jun 30, 2023 10-Q 2023-08-14
Q1 2023 $142M -$61.1M -30.2% Mar 31, 2023 10-Q 2023-05-15
Q4 2022 $168M -$57.7M -25.6% Dec 31, 2022 10-Q 2023-11-14
Q3 2022 $175M -$52M -22.9% Sep 30, 2022 10-Q 2022-11-10
Q2 2022 $182M -$48.3M -21% Jun 30, 2022 10-Q 2022-08-15
Q1 2022 $203M +$72.5M +55.7% Mar 31, 2022 10-Q 2022-05-12
Q4 2021 $225M +$93.5M +70.9% Dec 31, 2021 10-K 2023-03-31
Q3 2021 $227M Sep 30, 2021 10-Q 2021-11-12
Q2 2021 $230M Jun 30, 2021 10-Q 2021-08-12
Q1 2021 $130M Mar 31, 2021 10-Q 2021-06-14
Q4 2020 $132M Dec 31, 2020 10-K 2022-03-17
* An asterisk sign (*) next to the value indicates that the value is likely invalid.